Humana - HUM Stock Forecast, Price & News

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HUM shares.
View HUM analyst ratings or view top-rated stocks.

14 Wall Street research analysts have issued twelve-month price targets for Humana's stock. Their HUM share price forecasts range from $415.00 to $650.00. On average, they anticipate the company's share price to reach $579.00 in the next year. This suggests a possible upside of 5.9% from the stock's current price.
View analysts price targets for HUM or view top-rated stocks among Wall Street analysts.

Humana's stock was trading at $463.86 at the beginning of 2022. Since then, HUM stock has increased by 17.9% and is now trading at $546.78.
View the best growth stocks for 2022 here.

Humana saw a increase in short interest in November. As of November 15th, there was short interest totaling 2,670,000 shares, an increase of 29.6% from the October 31st total of 2,060,000 shares. Based on an average trading volume of 1,020,000 shares, the days-to-cover ratio is currently 2.6 days. Currently, 2.1% of the company's stock are short sold.
View Humana's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our HUM earnings forecast.

Humana Inc. (NYSE:HUM) released its quarterly earnings results on Wednesday, November, 3rd. The insurance provider reported $4.83 EPS for the quarter, topping analysts' consensus estimates of $4.61 by $0.22. The insurance provider earned $20.70 billion during the quarter, compared to analyst estimates of $20.91 billion. Humana had a trailing twelve-month return on equity of 19.99% and a net margin of 3.07%. The company's quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.08 earnings per share.
Read the conference call transcript.

Humana announced a quarterly dividend on Thursday, October 27th. Investors of record on Friday, December 30th will be given a dividend of $0.7875 per share on Friday, January 27th. This represents a $3.15 annualized dividend and a dividend yield of 0.58%. The ex-dividend date of this dividend is Thursday, December 29th.
Read our dividend analysis for HUM.

Humana (NYSE:HUM) pays an annual dividend of $3.15 per share and currently has a dividend yield of 0.58%. The company has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 14.29%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 11.26% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.

Humana issued an update on its FY 2023 earnings guidance on Thursday, December, 1st. The company provided earnings per share (EPS) guidance of $27.75-$28.75 for the period, compared to the consensus EPS estimate of $28.04. The company issued revenue guidance of -.

1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Humana's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.83%), Price T Rowe Associates Inc. MD (5.36%), State Street Corp (4.43%), Bank of New York Mellon Corp (1.34%), Newport Trust Co (1.07%) and Dimensional Fund Advisors LP (0.89%). Insiders that own company stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, David A Jr/Ky Jones, Elizabeth D Bierbower, Jorge S Mesquita, Joseph C Ventura, Samir Deshpande, Susan M Diamond, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends.

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HUM stock can currently be purchased for approximately $546.78.

Humana (NYSE:HUM) has a market capitalization of $69.22 billion and generates $83.06 billion in revenue each year. The insurance provider earns $2.93 billion in net income (profit) each year or $22.05 on an earnings per share basis.

The company employs 95,500 workers across the globe.

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The official website for the company is www.humana.com. The insurance provider can be reached via phone at (502) 580-1000, via email at amysmith@humana.com, or via fax at 502-580-3639.